May 13, 2021
Business News

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES–()–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ChemoCentryx, Inc. (“ChemoCentryx” or “the Company”) (NASDAQ: CCXI) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The FDA released a “Briefing Document” on May 4, 2021, concerning ChemoCentryx’s drug candidate avacopan. The FDA document notes that the agency’s review team “has identified several areas of concern, raising uncertainties about the interpretability of the data” found in the Company’s…

Click here to view the original article.

Related Posts

You might also like ...

Genius Sports to Announce First Quarter 2021 Results on May 20
Alibaba Group Announces March Quarter and Full Fiscal Year 2021 Results
The “Rare Disease Company Coalition” Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access